<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gao Z</submitter><funding>Independent Research Fund Denmark</funding><funding>Novo Nordisk Foundation</funding><funding>Carlsberg Foundation</funding><funding>Innovationsfonden</funding><funding>Lundbeck Foundation</funding><funding>Novo Nordisk Fonden</funding><pagination>2942-2951</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9481986</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>30(9)</volume><pubmed_abstract>Prime editing is a new CRISPR-based, genome-editing technology that relies on the prime editor (PE), a fusion protein of Cas9-nickase and M-MLV reverse transcriptase (RT), and a prime editing guide RNA (pegRNA) that serves both to target PE to the desired genomic locus and to carry the edit to be introduced. Here, we make advancements to the RT moiety to improve prime editing efficiencies and truncations to mitigate issues with adeno-associated virus (AAV) viral vector size limitations, which currently do not support efficient delivery of the large prime editing components. These efforts include RT variant screening, codon optimization, and PE truncation by removal of the RNase H domain and further trimming. This led to a codon-optimized and size-minimized PE that has an expression advanta</pubmed_abstract><journal>Molecular therapy : the journal of the American Society of Gene Therapy</journal><pubmed_title>A truncated reverse transcriptase enhances prime editing by split AAV vectors.</pubmed_title><pmcid>PMC9481986</pmcid><funding_grant_id>324-2019-1832</funding_grant_id><funding_grant_id>NNF19OC0058238</funding_grant_id><funding_grant_id>R303-2018-3571</funding_grant_id><pubmed_authors>Haldrup J</pubmed_authors><pubmed_authors>Ding X</pubmed_authors><pubmed_authors>Ravendran S</pubmed_authors><pubmed_authors>Mikkelsen NS</pubmed_authors><pubmed_authors>Bak RO</pubmed_authors><pubmed_authors>Gao Z</pubmed_authors><pubmed_authors>Thomsen MK</pubmed_authors><pubmed_authors>Mikkelsen JG</pubmed_authors><pubmed_authors>Cai H</pubmed_authors><pubmed_authors>Paludan SR</pubmed_authors></additional><is_claimable>false</is_claimable><name>A truncated reverse transcriptase enhances prime editing by split AAV vectors.</name><description>Prime editing is a new CRISPR-based, genome-editing technology that relies on the prime editor (PE), a fusion protein of Cas9-nickase and M-MLV reverse transcriptase (RT), and a prime editing guide RNA (pegRNA) that serves both to target PE to the desired genomic locus and to carry the edit to be introduced. Here, we make advancements to the RT moiety to improve prime editing efficiencies and truncations to mitigate issues with adeno-associated virus (AAV) viral vector size limitations, which currently do not support efficient delivery of the large prime editing components. These efforts include RT variant screening, codon optimization, and PE truncation by removal of the RNase H domain and further trimming. This led to a codon-optimized and size-minimized PE that has an expression advanta</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Sep</publication><modification>2025-04-05T00:09:27.207Z</modification><creation>2025-04-05T00:09:27.207Z</creation></dates><accession>S-EPMC9481986</accession><cross_references><pubmed>35808824</pubmed><doi>10.1016/j.ymthe.2022.07.001</doi></cross_references></HashMap>